Skip to main content

Cell-Free DNA Isolation and Extraction Market Trends, Share, Size, Growth, Opportunity and Forecast to 2031


 

The global cell-free DNA isolation and extraction market is expected to witness high growth, attributing to the rise in prevalence of cancer, increasing key player initiatives, and rising government initiatives in cell-free DNA isolation and extraction. The continued significant investments by healthcare companies to meet industry demand and the growing adoption of cell-free DNA isolation and extraction kits, tubes, and reagents among major end users are the major factors propelling the growth of the global cell-free DNA isolation and extraction market.

The use of cell-free DNA isolation and extraction kits, tubes, and other consumables has increased due to the rising prevalence of cancer, the increasing key player initiatives, and the rising government initiatives in the cell-free DNA isolation and extraction market. The constant significant investments by healthcare companies to meet industry demand and the growing adoption of cell-free DNA isolation and extraction kits, tubes, and reagents among major end users are the major factors propelling the growth of the global cell-free DNA isolation and extraction market. The global cell-free DNA isolation and extraction market was valued at $169.9 million in 2020 and is expected to reach $735.1 million by 2031, witnessing a CAGR of 14.19% during the forecast period 2021-2031.

Disruption in Global Cell-Free DNA Isolation and Extraction Market Due to COVID-19

The current global cell-free DNA isolation and extraction market study comprises consumables, instruments, and software that are utilized in cell-free DNA isolation and extraction testing. Since the market is primarily dominated by the research utility of products, the COVID-19 pandemic has had a massive impact on the growth of revenue generated from the market. The current market assessment has considered information provided by key opinion leaders in the market from both supply and demand sides.

Conjunctive analysis from respondent recommendations and BIS research analysis has concluded that during the period 2020-2022, the market is expected to witness a massive drop in year-on-year growth. The drop in the year-on-year growth is majorly attributed to the temporary halt in research activities pertaining to cell-free DNA isolation and extraction coupled with the low influx of cancer patients in hospitals due to the change in healthcare priorities on account of COVID-19.


Market Segmentation

•    Consumable - Cell-Free DNA Isolation and Extraction Kits, ell-Free DNA Isolation and Extraction Tubes, and Other Consumables

•    Platform - Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Other Platforms

•    Technique - Magnetic Beads-Based, Spin Column-Based, and Other Techniques

•    Application - Non-Invasive Prenatal Testing (NIPT), Oncology, Transplant Rejection, and Other Applications

•    End-User - Academic Research Institutes and Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Clinical Diagnostic Centers, and Other End Users.


Regional Segmentation

•    North America - U.S., Canada

•    Europe - Germany, U.K., France, Italy, Spain, Denmark, and Rest-of-Europe

•    Asia-Pacific - China, India, Japan, Singapore, South Korea, Australia, and Rest-of-Asia-Pacific

•    Rest-of-the-World


Competitive Landscape

The global cell-free DNA isolation and extraction market comprise well-established and newly emerging companies. Several companies are attempting to sustain their position in the market by launching new products and raising funds to develop new products for the isolation and extraction of cell-free DNA from different sample types. Key market players of the global cell-free DNA isolation and extraction market witnessed product launch, product approval and business funding, and synergistic activities majorly during the period January 2018-November 2021. The inclination of companies toward product launches suggests that the companies are involved in continuously bringing new products to the market to isolate cell-free DNA, which is primarily attributed to an increase in liquid biopsy studies and approval of several liquid biopsy assays by the regulatory agencies.


Market Dynamics of Cell-Free DNA Isolation and Extraction Market 

 

Key Companies Profiled

Thermo Fisher Scientific Inc., QIAGEN, Danaher, PerkinElmer, Inc., Endress+Hauser AG, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Illumina, Inc., Takara Bio Inc., Aline Biosciences , EpiGentek Group, Inc., Omega Bio-tek, Inc., Promega Corporation, Streck, Inc., AccuBioMed Co., Ltd., AMSBIO, Covaris, Inc., EntroGen, Inc., NeoGeneStar LLC, Norgen Biotek Corp., STRATEC SE, System Biosciences, LLC, Vela Diagnostics

For Market Research Subscription - https://bisresearch.com/our-offerings/subscriptions

Key Questions Answered in this Report:

• How is cell-free DNA isolation and extraction revolutionizing oncology?
• What are the major market drivers, challenges, and opportunities in the global cell-free DNA isolation and extraction market?
• What are the underlying structures resulting in the emerging trends within the global cell-free DNA isolation and extraction market?
• How is the COVID-19 pandemic impacting the global cell-free DNA isolation and extraction ecosystem?
• What are the key development strategies that the major players are implementing in order to sustain themselves in the competitive market?
• What are the key regulatory implications in developed and developing regions pertaining to the use of cell-free DNA isolation and extraction-targeted therapies?
• What are the potential entry barriers expected to be faced by the companies willing to enter a particular region?
• How is each market segment expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
o Consumable (Cell-Free DNA Isolation and Extraction Kits, Cell-Free DNA Isolation and Extraction Tubes, and Other Consumables)
o Platform (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Other Platforms)
o Technique (Magnetic Beads-Based, Spin Column-Based, and Other Techniques)
o Application (Non-Invasive Prenatal Testing (NIPT), Oncology, Transplant Rejection, and Other Applications)
o End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), and Other End Users)
o Region (North America, Europe, Asia-Pacific, and Rest-of-the-World)
• What are the growth opportunities for the cell-free DNA isolation and extraction companies in the region of their operation?
• Who are the leading players with significant offerings in the global cell-free DNA isolation and extraction market?
• Which companies are anticipated to be highly disruptive in the future, and why?

Request a Sample - https://bisresearch.com/requestsample?id=1251type=download

BIS Related Studies

 

Global Non-Invasive Prenatal Testing (NIPT) Market

Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: •     Industry Analysis    ...
Post a Comment
Read more

Hyperspectral Imaging Market Projections , Upcoming Trends Focus on Long-Term Impact of Covid-19 and Forecast By 2027

  The global  hyperspectral imaging market  was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining. The hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense sectors, increased food safety concerns, and increasing awareness regarding early diagnosis of diseases.   COVID-19 Impact and Post-COVID-19 Scenario The COVID-19 pandemic had a debilitating impact on the global ecosystem. The pandemic led to a shutdown of production facilities, which do not come under essential goods, which led to a negative impact on se...
Post a Comment
Read more